Novel insights into Parkin-mediated mitochondrial dysfunction and neuroinflammation in Parkinson's disease
Current Opinion in Neurobiology · 2023-06 · 80 · 102720
DOI: 10.1016/j.conb.2023.102720 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Opinion in Neurobiology, 2023-06. Verfasst von Sandro L Pereira und 4 weiteren Autor:innen. Beteiligte Einrichtung: Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg. Hauptthemen laut MEDLINE: Protein Kinases, Parkinson Disease. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hermann und Lilly Schilling-Stiftung für Medizinische Forschung, Fonds National de la Recherche Luxembourg, Michael J Fox Foundation for Parkinson's Research.
Abstract (Originalsprache)
Mutations in PRKN cause the second most common genetic form of Parkinson's disease (PD)-a debilitating movement disorder that is on the rise due to population aging in the industrial world. PRKN codes for an E3 ubiquitin ligase that has been well established as a key regulator of mitophagy. Together with PTEN-induced kinase 1 (PINK1), Parkin controls the lysosomal degradation of depolarized mitochondria. But Parkin's functions go well beyond mitochondrial clearance: the versatile protein is involved in mitochondria-derived vesicle formation, cellular metabolism, calcium homeostasis, mitochondrial DNA maintenance, mitochondrial biogenesis, and apoptosis induction. Moreover, Parkin can act as a modulator of different inflammatory pathways. In the current review, we summarize the latest literature concerning the diverse roles of Parkin in maintaining a healthy mitochondrial pool. Moreover, we discuss how these recent discoveries may translate into personalized therapeutic approaches not only for PRKN-PD patients but also for a subset of idiopathic cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
- Translational Neurodegeneration Section "Albrecht Kossel", Department of Neurology, University Medical Center Rostock, University of Rostock, Rostock, Germany.
- Translational Neurodegeneration Section "Albrecht Kossel", Department of Neurology, University Medical Center Rostock, University of Rostock, Rostock, Germany; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)…
- Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg; Institute of Neurogenetics, University of Lübeck, Lübeck, Germany. Electronic address: anne.gruenewald@uni.lu.
Förderung
- Hermann und Lilly Schilling-Stiftung für Medizinische Forschung
- Fonds National de la Recherche Luxembourg
- Michael J Fox Foundation for Parkinson's Research
Zitieren
APA
Pereira, S. L., Grossmann, D., Delcambre, S., Hermann, A., & Grünewald, A. (2023). Novel insights into Parkin-mediated mitochondrial dysfunction and neuroinflammation in Parkinson's disease. Current Opinion in Neurobiology, 80, 102720. https://doi.org/10.1016/j.conb.2023.102720
Vancouver
Pereira SL, Grossmann D, Delcambre S, Hermann A, Grünewald A. Novel insights into Parkin-mediated mitochondrial dysfunction and neuroinflammation in Parkinson's disease. Current Opinion in Neurobiology. 2023;80:102720. doi:10.1016/j.conb.2023.102720
BibTeX
@article{Pereira2023,
author = {Pereira, Sandro L and Grossmann, Dajana and Delcambre, Sylvie and Hermann, Andreas and Grünewald, Anne},
title = {Novel insights into Parkin-mediated mitochondrial dysfunction and neuroinflammation in Parkinson's disease},
journal = {Current Opinion in Neurobiology},
year = {2023},
volume = {80},
pages = {102720},
doi = {10.1016/j.conb.2023.102720}
}
EUVIMED